Jitian Li
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Immunotherapy and Immune Responses
Papers in
-
- Glycosylation and Glycoproteins Research 4
- Circular RNAs in diseases 3
-
- Monoclonal and Polyclonal Antibodies Research 9
- Co-authors
- Liping Dai (12 shared papers)Jian-Ying Zhang (9 shared papers)Xiaofeng Dai (4 shared papers)Jianying Zhang (5 shared papers)Carlos A. Casiano (4 shared papers)Yan Ma (5 shared papers)Harvey I. Pass (2 shared papers)Eng M. Tan (2 shared papers)
- Journals
- Tumor Biology (3 papers)Oncotarget (2 papers)OncoImmunology (2 papers)Inflammation Research (1 paper)Cell Death Discovery (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Jitian Li
29 papers receiving 608 citations
Peers
Comparison fields: 5 of 83
- Cancer Research 155
- Immunology 155
- Radiology, Nuclear Medicine and Imaging 149
- Oncology 142
- Molecular Biology 336
Countries citing papers authored by Jitian Li
This map shows the geographic impact of Jitian Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jitian Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jitian Li more than expected).
Fields of papers citing papers by Jitian Li
This network shows the impact of papers produced by Jitian Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jitian Li. The network helps show where Jitian Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Jitian Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 60 | |
| 2 | 2018 | 49 | |
| 3 | 2017 | 44 | |
| 4 | 2020 | 43 | |
| 5 | 2020 | 38 | |
| 6 | 2017 | 35 | |
| 7 | 2014 | 34 | |
| 8 | 2019 | 33 | |
| 9 | 2023 | 26 | |
| 10 | 2017 | 26 | |
| 11 | 2016 | 26 | |
| 12 | 2016 | 21 | |
| 13 | 2014 | 20 | |
| 14 | 2022 | 19 | |
| 15 | 2020 | 18 | |
| 16 | 2014 | 17 | |
| 17 | 2020 | 15 | |
| 18 | 2024 | 13 | |
| 19 | 2021 | 12 | |
| 20 | 2021 | 11 |
About Jitian Li
Jitian Li is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging, Immunology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 29 papers that have together received 615 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (9 papers), Monoclonal and Polyclonal Antibodies Research (9 papers), Glycosylation and Glycoproteins Research (4 papers), MicroRNA in disease regulation (3 papers), Circular RNAs in diseases (3 papers), Lymphoma Diagnosis and Treatment (3 papers), Prostate Cancer Treatment and Research (3 papers) and Long-Term Effects of COVID-19 (2 papers). The work is most often cited by research in Cancer Research (155 citations), Immunology (155 citations), Radiology, Nuclear Medicine and Imaging (149 citations), Oncology (142 citations) and Molecular Biology (336 citations). Jitian Li has collaborated with scholars based in China and United States. Frequent co-authors include Liping Dai, Jian-Ying Zhang, Xiaofeng Dai, Jianying Zhang, Carlos A. Casiano, Yan Ma, Harvey I. Pass, Eng M. Tan, Ting-An Yie and William N. Rom. Their work appears in journals such as Tumor Biology, Oncotarget, OncoImmunology, Inflammation Research and Cell Death Discovery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.